212 related articles for article (PubMed ID: 33601148)
1. HMGCS1 drives drug-resistance in acute myeloid leukemia through endoplasmic reticulum-UPR-mitochondria axis.
Zhou C; Li J; Du J; Jiang X; Xu X; Liu Y; He Q; Liang H; Fang P; Zhan H; Zeng H
Biomed Pharmacother; 2021 May; 137():111378. PubMed ID: 33601148
[TBL] [Abstract][Full Text] [Related]
2. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
3. VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines.
El Dor M; Dakik H; Polomski M; Haudebourg E; Brachet M; Gouilleux F; Prié G; Zibara K; Mazurier F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751795
[TBL] [Abstract][Full Text] [Related]
4. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
[TBL] [Abstract][Full Text] [Related]
5. Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia.
Zhou C; Wang Z; Yang S; Li H; Zhao L
Front Oncol; 2022; 12():864430. PubMed ID: 35847946
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of GLI3 Expression Mediates Chemotherapy Resistance in Acute Myeloid Leukemia.
Freisleben F; Behrmann L; Thaden V; Muschhammer J; Bokemeyer C; Fiedler W; Wellbrock J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708452
[TBL] [Abstract][Full Text] [Related]
7. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.
Salaroglio IC; Panada E; Moiso E; Buondonno I; Provero P; Rubinstein M; Kopecka J; Riganti C
Mol Cancer; 2017 May; 16(1):91. PubMed ID: 28499449
[TBL] [Abstract][Full Text] [Related]
8. Tunicamycin-induced unfolded protein response in the developing mouse brain.
Wang H; Wang X; Ke ZJ; Comer AL; Xu M; Frank JA; Zhang Z; Shi X; Luo J
Toxicol Appl Pharmacol; 2015 Mar; 283(3):157-67. PubMed ID: 25620058
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
Xu D; Liang SQ; Yang H; Lüthi U; Riether C; Berezowska S; Marti TM; Hall SRR; Bruggmann R; Kocher GJ; Schmid RA; Peng RW
Br J Cancer; 2018 Jul; 119(1):65-75. PubMed ID: 29921948
[TBL] [Abstract][Full Text] [Related]
11. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.
Li Q; Song W; Wang J
Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433
[TBL] [Abstract][Full Text] [Related]
12. Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia.
Śniegocka M; Liccardo F; Fazi F; Masciarelli S
Drug Resist Updat; 2022 Sep; 64():100853. PubMed ID: 35870226
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
14. Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.
Zhe N; Wang J; Chen S; Lin X; Chai Q; Zhang Y; Zhao J; Fang Q
Hematology; 2015 Aug; 20(7):384-91. PubMed ID: 26218201
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
Kang Y; Zhang S; Cao W; Wan D; Sun L
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
[TBL] [Abstract][Full Text] [Related]
16. MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
Wang CC; Liu HE; Lee YL; Huang YW; Chen YJ; Liou JP; Huang HM
Tumour Biol; 2016 May; 37(5):6065-72. PubMed ID: 26608370
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of mitochondrial ATPsyn-β in acute myeloid leukemia cells and with increased drug resistance.
Xiao X; Yang J; Li R; Liu S; Xu Y; Zheng W; Yi Y; Luo Y; Gong F; Peng H; Pei M; Deng M; Zhang G
PLoS One; 2013; 8(12):e83610. PubMed ID: 24391795
[TBL] [Abstract][Full Text] [Related]
18. Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
Karathedath S; Rajamani BM; Musheer Aalam SM; Abraham A; Varatharajan S; Krishnamurthy P; Mathews V; Velayudhan SR; Balasubramanian P
PLoS One; 2017; 12(5):e0177227. PubMed ID: 28505160
[TBL] [Abstract][Full Text] [Related]
19. Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin.
Liu H; Liu M; Zhang J; Liang Y
Mol Med Rep; 2020 Oct; 22(4):2810-2816. PubMed ID: 32945422
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs.
Rodrigo R; Mendis N; Ibrahim M; Ma C; Kreinin E; Roma A; Berg S; Blay J; Spagnuolo PA
Autophagy; 2019 May; 15(5):900-907. PubMed ID: 30563411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]